|
FDA Inspectional Resources May Shift to High-Risk Products
Manufacturers of potentially high-risk medical devices may find themselves subject to greater FDA scrutiny as the agency considers overhauling its inspection program in light of mounting device safety concerns, particularly for implantable cardiac devices. This article is viewable by subscribers only. To view this article, please select an option below.
|
Subscribe
Archives